Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
- PMID: 32653420
- PMCID: PMC7347494
- DOI: 10.1016/j.amjmed.2020.06.005
Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era
Erratum in
-
Erratum to "Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era" AmJMed, 133(11); 1254-1261.Am J Med. 2021 Apr;134(4):555. doi: 10.1016/j.amjmed.2021.01.001. Epub 2021 Jan 9. Am J Med. 2021. PMID: 33461734 Free PMC article. No abstract available.
Abstract
It is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19. We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.
Keywords: COVID-19; Cardiovascular consult; Cardiovascular disease; Multidisciplinary care; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures




References
-
- Lala A, Johnson KW, Januzzi JL, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection [e-pub ahead of print]. J Am Coll Cardiol Available at: https://doi:10.1016/j.jacc.2020.06.007. Accessed June 8, 2020. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous